V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300003526 | 300002458 | 1.6 | 82.1 | Curative (C) | null | 2016-09-08 | Capecitabine | Y | null | 300015914 | CAPECITABINE |
| 300003527 | 300002459 | null | 85 | null | 2014-09-21 | 2014-10-05 | Cisplatin + Docetaxel +Fluorouracil | null | N | 300015916 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003528 | 300002460 | 1.67 | 58 | null | 2015-11-06 | 2015-11-06 | NPC Cisplatin/5 flourouracil | N | N | 300015917 | CISPLATIN + FLUOROURACIL |
| 300003529 | 300002461 | null | null | Adjuvant (A) | 2013-06-24 | 2013-07-19 | Capecitabine | 02 | N | 300015918 | CAPECITABINE |
| 300003530 | 300002462 | 1.58 | 74.6 | null | null | 2017-02-10 | Cetuximab 7 day (Cycle 1) | null | null | 300015919 | CETUXIMAB |
| 300003531 | 300002463 | 1.6 | 65 | null | 2016-10-24 | 2016-10-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 300015921 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003532 | 300002463 | 1.87 | 124 | null | 2016-12-17 | 2016-12-17 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015921 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003533 | 300002464 | 1.49 | null | Neo-adjuvant (N) | 2016-11-24 | 2016-11-25 | Cetuximab 7 day (Cycle 1) | 2 | null | 300015931 | CETUXIMAB |
| 300003534 | 300002465 | 1.58 | 86.4 | Adjuvant (A) | 2016-07-31 | 2016-08-02 | Capecitabine | N | N | 300015934 | CAPECITABINE |
| 300003535 | 300002466 | 1.67 | 92 | null | 2014-10-17 | 2014-10-17 | Cisplatin +Fluorouracil (3 wk) | 02 | null | 300015936 | CISPLATIN + FLUOROURACIL |
| 300003536 | 300002467 | 1.84 | 90.5 | Neo-adjuvant (N) | 2013-05-22 | 2013-05-28 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300015937 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003537 | 300005953 | 1.6 | 63 | Neo-adjuvant (N) | null | 2015-05-21 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015942 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003538 | 300002468 | null | null | 3 | null | 2018-02-09 | Cisplatin +Fluorouracil (3 wk) | null | null | 300015944 | CISPLATIN + FLUOROURACIL |
| 300003539 | 300002468 | 1.99 | null | Neo-adjuvant (N) | null | 2015-06-29 | Cisplatin + Docetaxel +Fluorouracil | null | null | 300015944 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003540 | 300002469 | 1.67 | 64.9 | Neo-adjuvant (N) | 2014-10-19 | 2014-10-19 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 300015949 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003541 | 300002470 | 1.68 | 87 | Neo-adjuvant (N) | 2014-02-14 | 2014-02-28 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015951 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003542 | 300002470 | 1.72 | null | Curative (C) | 2016-06-23 | 2016-07-19 | Trial Unspecified | 02 | N | 300015951 | TRIAL |
| 300003543 | 300002471 | 1.6 | 67 | Adjuvant (A) | 2016-05-22 | 2016-05-27 | Capecitabine | N | N | 300015959 | CAPECITABINE |
| 300003544 | 300002471 | 1.69 | 81.4 | Palliative (P) | 2017-04-24 | 2017-05-06 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 300015959 | CARBOPLATIN + PACLITAXEL |
| 300003545 | 300002472 | 1.6 | 79 | Curative (C) | null | 2016-12-12 | Cetuximab + Radiotherapy Load | null | Y | 300015961 | CETUXIMAB + RT |
| 300003546 | 300002473 | 1.67 | 44 | Curative (C) | 2014-12-22 | 2015-01-04 | Cetuximab 7 day (Cycle 1) | N | Y | 300015964 | CETUXIMAB |
| 300003547 | 300002474 | 1.75 | 88 | Neo-adjuvant (N) | 2014-05-27 | 2014-06-04 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300015969 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003548 | 300002475 | 1.7 | 74.7 | Palliative (P) | 2013-12-31 | 2014-01-06 | Cisplatin +Fluorouracil (3 wk) | 02 | null | 300015970 | CISPLATIN + FLUOROURACIL |
| 300003549 | 300002476 | 1.71 | null | Neo-adjuvant (N) | 2015-09-23 | 2015-09-30 | Cisplatin + Docetaxel +Fluorouracil | Y | N | 300015978 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003550 | 300002477 | null | null | Neo-adjuvant (N) | 2014-06-30 | 2014-07-08 | Cisplatin + Docetaxel +Fluorouracil | N | Y | 300015979 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003551 | 300002478 | 1.66 | 94 | Palliative (P) | 2015-05-05 | 2015-05-19 | Capecitabine | N | N | 300015980 | CAPECITABINE |
| 300003552 | 300002479 | 1.59 | 91 | Neo-adjuvant (N) | 2016-10-14 | 2016-10-28 | CISPLATIN + FLUOROURACIL | Y | N | 300015981 | CISPLATIN + FLUOROURACIL |
| 300003553 | 300002480 | 1.6 | null | Curative (C) | 2018-02-07 | 2018-02-20 | Cetuximab + Radiotherapy Load | N | Y | 300015988 | CETUXIMAB + RT |
| 300003554 | 300002481 | 1.79 | 75 | null | 2014-04-20 | 2014-04-20 | CETUXIMAB | Y | Y | 300015989 | CETUXIMAB |
| 300003555 | 300002482 | null | 62 | Neo-adjuvant (N) | 2013-08-19 | 2013-08-31 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300015990 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003556 | 300002483 | 1.6 | 101 | Curative (C) | 2013-10-10 | 2013-10-26 | Cisplatin +Fluorouracil (2 wk) | 02 | N | 300015993 | CISPLATIN + FLUOROURACIL |
| 300003557 | 300002484 | null | 78.3 | Curative (C) | null | 2017-03-06 | Cisplatin + Docetaxel +Fluorouracil | null | null | 300015996 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003558 | 300002485 | 1.7 | null | Neo-adjuvant (N) | 2015-06-30 | 2015-07-02 | CISPLATIN + FLUOROURACIL | N | Y | 300016012 | CISPLATIN + FLUOROURACIL |
| 300003559 | 300002486 | 1.59 | null | null | 2015-09-23 | 2015-10-19 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 300016015 | CISPLATIN + FLUOROURACIL |
| 300003560 | 300002487 | 1.72 | 88 | Palliative (P) | 2014-07-09 | 2014-07-22 | Carboplatin + Paclitaxel (3 weekly) | N | N | 300016023 | CARBOPLATIN + PACLITAXEL |
| 300003561 | 300002488 | 1.64 | 54.5 | Curative (C) | 2014-06-25 | 2014-06-25 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300016037 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003562 | 300005957 | 1.8 | 65.2 | Palliative (P) | 2015-06-25 | 2015-07-09 | Trial Unspecified | 02 | N | 300016039 | TRIAL |
| 300003563 | 300002489 | 1.52 | 70 | Neo-adjuvant (N) | 2014-04-09 | 2014-04-09 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 300016042 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003564 | 300002490 | 1.57 | 65.4 | Neo-adjuvant (N) | 2016-06-19 | 2016-06-28 | CISPLATIN + FLUOROURACIL | N | N | 300016043 | CISPLATIN + FLUOROURACIL |
| 300003565 | 300002491 | null | 79.6 | Curative (C) | 2017-04-07 | 2017-04-14 | CETUXIMAB + RT | N | N | 300016047 | CETUXIMAB + RT |
| 300003566 | 300005958 | 1.7 | 99.4 | Curative (C) | 2015-10-11 | 2015-10-11 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300016051 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003567 | 300002492 | 1.6 | 59.1 | Curative (C) | 2014-07-23 | 2014-08-18 | Trial Unspecified | 02 | N | 300016054 | TRIAL |
| 300003570 | 300002494 | null | 84 | Neo-adjuvant (N) | null | 2013-12-29 | Cisplatin + Docetaxel +Fluorouracil | null | null | 300016064 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003571 | 300002495 | null | 57.05 | null | 2014-05-20 | 2014-06-12 | Trial Unspecified | 02 | N | 300016065 | TRIAL |
| 300003572 | 300005960 | 1.7 | 60 | Not known (9) | 2017-11-14 | 2017-11-15 | CARBOPLATIN + PACLITAXEL | 02 | N | 300016066 | CARBOPLATIN + PACLITAXEL |
| 300003573 | 300005960 | 1.58 | null | 3 | null | 2015-09-20 | CISPLATIN + FLUOROURACIL | null | null | 300016066 | CISPLATIN + FLUOROURACIL |
| 300003574 | 300002496 | 1.7 | 96.9 | Curative (C) | 2016-05-10 | 2016-05-10 | Cisplatin +Fluorouracil (3 wk) | N | N | 300016069 | CISPLATIN + FLUOROURACIL |
| 300003575 | 300002497 | 1.68 | 80 | Adjuvant (A) | 2015-01-31 | 2015-01-31 | Capecitabine | 2 | N | 300016071 | CAPECITABINE |
| 300003576 | 300002498 | 1.6 | null | Curative (C) | 2017-11-04 | 2017-11-26 | Capecitabine | N | N | 300016074 | CAPECITABINE |
| 300003577 | 300002499 | 1.77 | 74.7 | Palliative (P) | 2016-08-15 | 2016-08-15 | Capecitabine | N | N | 300016076 | CAPECITABINE |